In order to elucidate whether YB-1 was involved in the regulatory network of hepatic cancer initiating cells, extreme limiting dilution analysis (ELDA) [18], based on the sphere-forming assay in vitro, was used to analyze the cancer initiating cell frequency in hepatoma cells. Here, YBX1 is linked to liver cancer.